-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Medpace Holdings, Lowers Price Target to $450

Benzinga·04/24/2026 18:09:55
Listen to the news
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.